0
     

Report Added
Report already added
Tuberculosis Treatment Market - Global Outlook and Forecast 2022-2028

Tuberculosis Treatment Market - Global Outlook and Forecast 2022-2028

This report contains market size and forecasts of Tuberculosis Treatment in Global, including the following market information:

Global Tuberculosis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Tuberculosis Treatment market was valued at 1047.7 million in 2021 and is projected to reach US$ 1289.9 million by 2028, at a CAGR of 3.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Active TB Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Tuberculosis Treatment include Sanofi, Bayer, Eli Lilly, Labatec Pharma, Macleods Pharmaceuticals, Mylan, Novatis, Otsuka and Patheon and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tuberculosis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Tuberculosis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Tuberculosis Treatment Market Segment Percentages, by Type, 2021 (%)
Active TB
Latent TB
Global Tuberculosis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Tuberculosis Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Global Tuberculosis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Tuberculosis Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tuberculosis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Tuberculosis Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Bayer
Eli Lilly
Labatec Pharma
Macleods Pharmaceuticals
Mylan
Novatis
Otsuka
Patheon
Pfizer
Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Tuberculosis Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tuberculosis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tuberculosis Treatment Overall Market Size
2.1 Global Tuberculosis Treatment Market Size: 2021 VS 2028
2.2 Global Tuberculosis Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Tuberculosis Treatment Players in Global Market
3.2 Top Global Tuberculosis Treatment Companies Ranked by Revenue
3.3 Global Tuberculosis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Tuberculosis Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Tuberculosis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Tuberculosis Treatment Players in Global Market
3.6.1 List of Global Tier 1 Tuberculosis Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Tuberculosis Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Tuberculosis Treatment Market Size Markets, 2021 & 2028
4.1.2 Active TB
4.1.3 Latent TB
4.2 By Type - Global Tuberculosis Treatment Revenue & Forecasts
4.2.1 By Type - Global Tuberculosis Treatment Revenue, 2017-2022
4.2.2 By Type - Global Tuberculosis Treatment Revenue, 2023-2028
4.2.3 By Type - Global Tuberculosis Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Tuberculosis Treatment Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Tuberculosis Treatment Revenue & Forecasts
5.2.1 By Application - Global Tuberculosis Treatment Revenue, 2017-2022
5.2.2 By Application - Global Tuberculosis Treatment Revenue, 2023-2028
5.2.3 By Application - Global Tuberculosis Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Tuberculosis Treatment Market Size, 2021 & 2028
6.2 By Region - Global Tuberculosis Treatment Revenue & Forecasts
6.2.1 By Region - Global Tuberculosis Treatment Revenue, 2017-2022
6.2.2 By Region - Global Tuberculosis Treatment Revenue, 2023-2028
6.2.3 By Region - Global Tuberculosis Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Tuberculosis Treatment Revenue, 2017-2028
6.3.2 US Tuberculosis Treatment Market Size, 2017-2028
6.3.3 Canada Tuberculosis Treatment Market Size, 2017-2028
6.3.4 Mexico Tuberculosis Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Tuberculosis Treatment Revenue, 2017-2028
6.4.2 Germany Tuberculosis Treatment Market Size, 2017-2028
6.4.3 France Tuberculosis Treatment Market Size, 2017-2028
6.4.4 U.K. Tuberculosis Treatment Market Size, 2017-2028
6.4.5 Italy Tuberculosis Treatment Market Size, 2017-2028
6.4.6 Russia Tuberculosis Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Tuberculosis Treatment Market Size, 2017-2028
6.4.8 Benelux Tuberculosis Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Tuberculosis Treatment Revenue, 2017-2028
6.5.2 China Tuberculosis Treatment Market Size, 2017-2028
6.5.3 Japan Tuberculosis Treatment Market Size, 2017-2028
6.5.4 South Korea Tuberculosis Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Tuberculosis Treatment Market Size, 2017-2028
6.5.6 India Tuberculosis Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Tuberculosis Treatment Revenue, 2017-2028
6.6.2 Brazil Tuberculosis Treatment Market Size, 2017-2028
6.6.3 Argentina Tuberculosis Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Tuberculosis Treatment Revenue, 2017-2028
6.7.2 Turkey Tuberculosis Treatment Market Size, 2017-2028
6.7.3 Israel Tuberculosis Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Tuberculosis Treatment Market Size, 2017-2028
6.7.5 UAE Tuberculosis Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Sanofi
7.1.1 Sanofi Corporate Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Tuberculosis Treatment Major Product Offerings
7.1.4 Sanofi Tuberculosis Treatment Revenue in Global Market (2017-2022)
7.1.5 Sanofi Key News
7.2 Bayer
7.2.1 Bayer Corporate Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Tuberculosis Treatment Major Product Offerings
7.2.4 Bayer Tuberculosis Treatment Revenue in Global Market (2017-2022)
7.2.5 Bayer Key News
7.3 Eli Lilly
7.3.1 Eli Lilly Corporate Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Tuberculosis Treatment Major Product Offerings
7.3.4 Eli Lilly Tuberculosis Treatment Revenue in Global Market (2017-2022)
7.3.5 Eli Lilly Key News
7.4 Labatec Pharma
7.4.1 Labatec Pharma Corporate Summary
7.4.2 Labatec Pharma Business Overview
7.4.3 Labatec Pharma Tuberculosis Treatment Major Product Offerings
7.4.4 Labatec Pharma Tuberculosis Treatment Revenue in Global Market (2017-2022)
7.4.5 Labatec Pharma Key News
7.5 Macleods Pharmaceuticals
7.5.1 Macleods Pharmaceuticals Corporate Summary
7.5.2 Macleods Pharmaceuticals Business Overview
7.5.3 Macleods Pharmaceuticals Tuberculosis Treatment Major Product Offerings
7.5.4 Macleods Pharmaceuticals Tuberculosis Treatment Revenue in Global Market (2017-2022)
7.5.5 Macleods Pharmaceuticals Key News
7.6 Mylan
7.6.1 Mylan Corporate Summary
7.6.2 Mylan Business Overview
7.6.3 Mylan Tuberculosis Treatment Major Product Offerings
7.6.4 Mylan Tuberculosis Treatment Revenue in Global Market (2017-2022)
7.6.5 Mylan Key News
7.7 Novatis
7.7.1 Novatis Corporate Summary
7.7.2 Novatis Business Overview
7.7.3 Novatis Tuberculosis Treatment Major Product Offerings
7.7.4 Novatis Tuberculosis Treatment Revenue in Global Market (2017-2022)
7.7.5 Novatis Key News
7.8 Otsuka
7.8.1 Otsuka Corporate Summary
7.8.2 Otsuka Business Overview
7.8.3 Otsuka Tuberculosis Treatment Major Product Offerings
7.8.4 Otsuka Tuberculosis Treatment Revenue in Global Market (2017-2022)
7.8.5 Otsuka Key News
7.9 Patheon
7.9.1 Patheon Corporate Summary
7.9.2 Patheon Business Overview
7.9.3 Patheon Tuberculosis Treatment Major Product Offerings
7.9.4 Patheon Tuberculosis Treatment Revenue in Global Market (2017-2022)
7.9.5 Patheon Key News
7.10 Pfizer
7.10.1 Pfizer Corporate Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Tuberculosis Treatment Major Product Offerings
7.10.4 Pfizer Tuberculosis Treatment Revenue in Global Market (2017-2022)
7.10.5 Pfizer Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Tuberculosis Treatment Market Opportunities & Trends in Global Market
Table 2. Tuberculosis Treatment Market Drivers in Global Market
Table 3. Tuberculosis Treatment Market Restraints in Global Market
Table 4. Key Players of Tuberculosis Treatment in Global Market
Table 5. Top Tuberculosis Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Tuberculosis Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Tuberculosis Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Tuberculosis Treatment Product Type
Table 9. List of Global Tier 1 Tuberculosis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tuberculosis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Tuberculosis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Tuberculosis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Tuberculosis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Tuberculosis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Tuberculosis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Tuberculosis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Tuberculosis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Tuberculosis Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Tuberculosis Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Tuberculosis Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Tuberculosis Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Tuberculosis Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Tuberculosis Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Tuberculosis Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Tuberculosis Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Tuberculosis Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Tuberculosis Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Tuberculosis Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Tuberculosis Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Sanofi Corporate Summary
Table 31. Sanofi Tuberculosis Treatment Product Offerings
Table 32. Sanofi Tuberculosis Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Bayer Corporate Summary
Table 34. Bayer Tuberculosis Treatment Product Offerings
Table 35. Bayer Tuberculosis Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Eli Lilly Corporate Summary
Table 37. Eli Lilly Tuberculosis Treatment Product Offerings
Table 38. Eli Lilly Tuberculosis Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Labatec Pharma Corporate Summary
Table 40. Labatec Pharma Tuberculosis Treatment Product Offerings
Table 41. Labatec Pharma Tuberculosis Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Macleods Pharmaceuticals Corporate Summary
Table 43. Macleods Pharmaceuticals Tuberculosis Treatment Product Offerings
Table 44. Macleods Pharmaceuticals Tuberculosis Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Mylan Corporate Summary
Table 46. Mylan Tuberculosis Treatment Product Offerings
Table 47. Mylan Tuberculosis Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Novatis Corporate Summary
Table 49. Novatis Tuberculosis Treatment Product Offerings
Table 50. Novatis Tuberculosis Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Otsuka Corporate Summary
Table 52. Otsuka Tuberculosis Treatment Product Offerings
Table 53. Otsuka Tuberculosis Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Patheon Corporate Summary
Table 55. Patheon Tuberculosis Treatment Product Offerings
Table 56. Patheon Tuberculosis Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Pfizer Corporate Summary
Table 58. Pfizer Tuberculosis Treatment Product Offerings
Table 59. Pfizer Tuberculosis Treatment Revenue (US$, Mn), (2017-2022)

List of Figures
Figure 1. Tuberculosis Treatment Segment by Type in 2021
Figure 2. Tuberculosis Treatment Segment by Application in 2021
Figure 3. Global Tuberculosis Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Tuberculosis Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Tuberculosis Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Tuberculosis Treatment Revenue in 2021
Figure 8. By Type - Global Tuberculosis Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Tuberculosis Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Tuberculosis Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Tuberculosis Treatment Revenue Market Share, 2017-2028
Figure 12. US Tuberculosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Tuberculosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Tuberculosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Tuberculosis Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Tuberculosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Tuberculosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Tuberculosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Tuberculosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Tuberculosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Tuberculosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Tuberculosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Tuberculosis Treatment Revenue Market Share, 2017-2028
Figure 24. China Tuberculosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Tuberculosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Tuberculosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Tuberculosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Tuberculosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Tuberculosis Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Tuberculosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Tuberculosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Tuberculosis Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Tuberculosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Tuberculosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Tuberculosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Tuberculosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Sanofi Tuberculosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bayer Tuberculosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Eli Lilly Tuberculosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Labatec Pharma Tuberculosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Macleods Pharmaceuticals Tuberculosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Mylan Tuberculosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Novatis Tuberculosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Otsuka Tuberculosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Patheon Tuberculosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Pfizer Tuberculosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Report Title: Tuberculosis Treatment Market - Global Outlook and Forecast 2022-2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Global Retinal Surgery Devices Market (By Device Segment, Application, Regional Analysis), Impact of COVID-19, Company Profiles, Major Deals, Strategy and Recent Developments – Forecast to 2027

Global Retinal Surgery Devices Market (By Device Segment, Application, Regional Analysis), Impact of COVID-19, Company Profiles, Major Deals, Strategy and Recent Developments – Forecast to 2027

Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Impact of COVID-19, Recent Developments, Company Profiles - Forecast to 2028

Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Impact of COVID-19, Recent Developments, Company Profiles - Forecast to 2028

Animal Wound Care Market by Product (Surgical (Sutures & Staplers, Glues), Advanced (Hydrocolloid, Hydrogel Dressings), Traditional (Tape, Dressings, Bandages), Animal Type (Cats, Dogs, Horse, Pigs), End User (Hospital, Clinics) - Global Forecast to 2027

Animal Wound Care Market by Product (Surgical (Sutures & Staplers, Glues), Advanced (Hydrocolloid, Hydrogel Dressings), Traditional (Tape, Dressings, Bandages), Animal Type (Cats, Dogs, Horse, Pigs), End User (Hospital, Clinics) - Global Forecast to 2027

Veterinary Ultrasound Market by Type (2D, 3D/4D, Doppler), Product (Portable Scanners), Technology (Contrast, Digital), Animal Type (Small, Large), Application (Gynecology, Cardiology, Orthopedics), End User (Clinics, Hospitals) - Global Forecast to 2027

Veterinary Ultrasound Market by Type (2D, 3D/4D, Doppler), Product (Portable Scanners), Technology (Contrast, Digital), Animal Type (Small, Large), Application (Gynecology, Cardiology, Orthopedics), End User (Clinics, Hospitals) - Global Forecast to 2027

Laboratory Animal Models, 3D Cultures and Organoids: Global Markets

Laboratory Animal Models, 3D Cultures and Organoids: Global Markets

Neuromodulation Market by Type (Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation)), Application (Parkinson's Disease, Depression, Urine incontinence, Epilepsy, Obesity) - Global Forecast to 2027

Neuromodulation Market by Type (Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation)), Application (Parkinson's Disease, Depression, Urine incontinence, Epilepsy, Obesity) - Global Forecast to 2027